Evidence map›Paper›PMID 25578797›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Upregulation of dopamine D2 receptors in the nucleus accumbens indirect pathway increases locomotion but does not reduce alcohol consumption.

Eduardo F Gallo, Michael C Salling, Bo Feng, Jose A Morón, Neil L Harrison, Jonathan A Javitch, Christoph Kellendonk

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 45 citations in OpenAlex.

  1. The sodium leak channel NALCN in Drd2Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Overexpression of wild type glycine alpha 1 subunit rescues ethanol sensitivity in accumbal receptors and reduces binge drinking in mice.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. A versatile GPCR toolkit to track in vivo neuromodulation: not a one-size-fits-all sensor.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  12. Article
  13. Article
  14. A Gain-of-Function Variant in Dopamine D2 Receptor and Progressive Chorea and Dystonia Phenotype.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eduardo F Gallo1] Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, USA [2] Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Michael C SallingDepartments of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Bo Feng1] Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, USA [2] Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Jose A MorónDepartments of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Neil L Harrison1] Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, USA [2] Departments of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Jonathan A Javitch1] Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, USA [2] Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Christoph Kellendonk1] Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY, USA [2] Division of Molecular Therapeutics, New York State Psychiatric Institute, New York, NY, USA.
Columbia University · USNew York Psychoanalytic Society and Institute · US

Funding

Structure of the Dopamine D2-Like Receptor Binding SitesR01MH054137 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI JAVITCH, JONATHAN A · 1995 to 2025
$12.0M
Medium Spiny Neuron Excitability and MotivationR01MH093672 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI KELLENDONK, CHRISTOPH · 2011 to 2020
$5.0M
AMPA receptors: Common role in opiate withdrawal and pain sensitivityR01DA027460 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CARLTON, SUSAN M, MORON-CONCEPCION, JOSE A · 2010 to 2014
$2.8M
Basic Neuroscience Training Grant at Columbia UniversityT32DA016224 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SULZER, DAVID · 2004 to 2011
$2.2M
Alcohol and Dopamine Release: Cellular and Synaptic MechanismsR01AA019801 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HARRISON, NEIL L., SULZER, DAVID · 2010 to 2014
$1.8M
Mechanisms underlying opiate-induced neuroplasticity at the synapseR01DA025036 · NIDA · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MORON-CONCEPCION, JOSE A · 2009 to 2013
$1.4M
Molecular Determinants for the Action of PsychostimulantsK05DA022413 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JAVITCH, JONATHAN A · 2007 to 2016
$1.3M
Alcohol and inhibition in the prefrontal cortexF32AA022028 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SALLING, MICHAEL CHARLES · 2012 to 2013
$101k
NIAAA NIH HHS 5F32AA022028NIAAA NIH HHS F32 AA022028NIAAA NIH HHS R01AA019801NIDA NIH HHS DA022413NIDA NIH HHS K05 DA022413NIDA NIH HHS R01DA025036NIDA NIH HHS R01DA027460NIDA NIH HHS T32DA016224NIMH NIH HHS MH093672NIMH NIH HHS MH54137NIMH NIH HHS R01 MH054137NIMH NIH HHS R01 MH093672
6 · The paper itself

Abstract

Brain imaging studies performed in humans have associated low striatal dopamine release and D2R binding with alcohol dependence. Conversely, high striatal D2R binding has been observed in unaffected members of alcoholic families suggesting that high D2R function may protect against alcohol dependence. A possible protective role of increased D2R levels in the striatum is further supported by preclinical studies in non-human primates and rodents. Here, we determined whether there is a causal relationship between D2R levels and alcohol intake. To this end, we upregulated D2R expression levels in the nucleus accumbens of the adult mouse, but selectively restricted the upregulation to the indirect striatal output pathway, which endogenously expresses D2Rs. After overexpression was established, mice were tested in two models of free-choice alcohol drinking: the continuous and intermittent access two-bottle choice models. As anticipated, we found that D2R upregulation leads to hyperactivity in the open field. Contrary to our expectation, D2R upregulation did not reduce alcohol intake during continuous or intermittent access or when alcohol drinking was tested in the context of aversive outcomes. These data argue against a protective role of accumbal indirect pathway D2Rs in alcohol consumption but emphasize their importance in promoting locomotor activity.

Indexed as

Alcohol DrinkingAlcoholsAnimalsConditioning, OperantExploratory BehaviorLocomotionLuminescent ProteinsMaleMiceMice, Inbred C57BLMice, TransgenicNeural PathwaysNeuronsNucleus AccumbensProtein BindingReceptors, Dopamine D2AlcoholsLuminescent ProteinsReceptors, Dopamine D2

Identifiers

PMID25578797
PMCPMC4915247
OpenAlexW2016558814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.